13D Filings
Vigil Neuroscience, Inc.
Amendment
Ownership

0.00%

Total Shares

0

Issuer CIK

1827087

CUSIP

92673K108

Event Date

May 21, 2025

Accepted

May 27, 2025, 06:26 PM

Reporting Persons (5)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Northpond Ventures, LP
Partnership
0.00%000
Northpond Ventures GP, LLC
Other
0.00%000
Northpond Ventures II, LP
Partnership
0.00%000
Northpond Ventures II GP, LLC
Other
0.00%000
Michael P. Rubin
Individual
0.00%000
Disclosure Items (2)

Security Title

Common Stock, $0.0001 par value per share

Issuer Name

Vigil Neuroscience, Inc.

Issuer Address

100 Forge Road, Suite 700, Watertown, MA, 02472

Percentage of Class

Rows 11 and 13 of each Reporting Person's cover page to this Schedule 13D/A set forth the aggregate number of shares of common stock and percentages of the shares of common stock beneficially owned by such Reporting Person and are incorporated by reference.

Number of Shares

Rows 7 through 10 of each Reporting Person's cover page to this Schedule 13D/A set forth the number of shares of common stock as to which such Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition and are incorporated by reference.

Transactions

Except as set forth below, none of the Reporting Persons has effected any transactions with respect to the securities of the Issuer during the past sixty days. Weighted Low High Reporting No. Average Price Price Transaction Person Date Shares Price ($) ($) ($) Open Market Sale Northpond LP 05/22/2025 2,831,520 7.89 7.82 8.08 Open Market Sale Northpond II LP 05/22/2025 1,382,978 7.89 7.82 8.08

Shareholders

No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the securities beneficially owned by any of the Reporting Persons.

Date of 5% Ownership

The Reporting Persons ceased to be the beneficial owners of more than five percent of the common stock on May 22, 2025.

Vigil Neuroscience, Inc. — Schedule 13D | 13D Filings